iRhythm Holdings, Inc. (IRTC) Latest Filing Signal

Based on earningsVibe SuperAnalyst™ synthesis of the latest 10-K, iRhythm Holdings, Inc.'s filing signal turned positive.

iRhythm Holdings, Inc. is a digital healthcare company specializing in ambulatory cardiac monitoring services, leveraging a proprietary system combining a wire-free, 14-day wearable biosensor with cloud-based data analytics software. The company's iRhythm ACM System is designed to help clinicians diagnose arrhythmias more quickly and efficiently than traditional methods. It has supported over twelve million patient reports since its FDA clearance in 2009, collecting nearly three billion hours of heartbeat data. The company primarily operates in the United States, with a growing international presence in the UK, Europe, and Japan. Revenue is primarily generated from third-party payors, including commercial insurers and government agencies like CMS, with approximately 24% of revenue coming from Medicare in 2025.

Revenue is driven by the provision of iRhythm Services, primarily through third-party payors (commercial and government) and healthcare institutions. The volume of services rendered and the reimbursement rates from these payors are key revenue drivers.